Evaluating transcatheter arterial chemoembolization for primary hepatic cancer by magnetic resonance diffusion-weighted imaging

Hepatic cancer is associated with very high mortality and morbidity, and the world＇s highest morbidity and mortality rates for this malignant tumor are found in China. Each year, the number of people who die of hepatic cancer in China amounts for 53% of the world total. Although resection is the first-choice treatment for hepatic cancer, only 20%-30% of patients have the opportunity to undergo resection. Transcatheter arterial chemoembolization （TACE） is a typical intervention therapy. Its advantages include minimal trauma, precise efficacy,